The intraperitoneal injection of DdBIC significantly suppressed tumor growth (Fig. 7j, top), with related events, including GSDMC and OPA1 cleavage, eIF2α phosphorylation, and a decrease in heme levels, detected in the same tumor samples (Fig. 7j, bottom). Here, GSDMC is linked to neoplasm.